Indacaterol

This classification denotes a beta-adrenergic agonist with the molecular formula C24H28N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8OR09251MQ, chemically known as 5-{(1r)-2-((5,6-diethyl-2,3-dihydro-1h-inden-2-yl)amino)-1-hydroxyethyl}-8-hydroxyquinolin-2(1h)-one but generally known as indacaterol, which bears US NIH Compound Identifier 6433117. European Medicines Agency schedules Indacaterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB30138. The term INDACATEROL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19, No. 1, 2005, List 53). World Health Organization schedules indacaterol in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule indacaterol under HS 29337900 and SITC 51561. As of Q4 2014, INDACATEROL remains the US FDA Preferred Term for this commodity. Indacaterol bears US NLM identifiers UMLS ID C1722260 and NCI Concept Code C81644. SMILES: OC(CNC1CC2C(C1)CC(C(C2)CC)CC)C1C2C([NH]C(=O)CC2)C(O)CC1.